Amphastar Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Amphastar Pharmaceuticals Inc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Amphastar Pharmaceuticals Inc Strategy Report

  • Understand Amphastar Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Amphastar Pharmaceuticals Inc: Overview

Select Item

Related keylists

Amphastar Pharmaceuticals Inc (Amphastar), is a specialty pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, intranasal and inhalation products. It sells insulin-active pharmaceutical ingredient products. The company’s key products include enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; lidocaine jelly; amphadase hyaluronidase injection; epinephrine, naloxone, phytonadione, primatene mist and glucagon. Amphastar offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products through subsidiaries, specialty distributors, wholesalers and retailers in the US, the UK, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

 Gain a 360-degree view of Amphastar Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Amphastar Pharmaceuticals Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 11570 6th St, Rancho Cucamonga, California, 91730
Website amphastar.com
Telephone 1 909 9809484
No of Employees 1,761
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange AMPH (NASD)
Revenue (2023) $644.4M
EPS XYZ
Market Cap* $1.9B
Net Profit Margin (2023) XYZ 16.6%
   
* As of and is in US$
View Amphastar Pharmaceuticals Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Amphastar Pharmaceuticals Inc premium industry data and analytics

50+

Marketed Drugs

Understand Amphastar Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

20+

Clinical Trials

Determine Amphastar Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

12+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Amphastar Pharmaceuticals Inc’s relevant decision makers and contact details.

8

Sales & Consensus Forecasts

Understand the current and future drug revenue for Amphastar Pharmaceuticals Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

8

Catalyst Calendar

Proactively evaluate Amphastar Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

7

Pipeline Drugs

Identify which of Amphastar Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Amphastar Pharmaceuticals Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Amphadase (hyaluronidase injection, USP) Amphadase
Cortrosyn (cosyntropin Injection) Luer-Jet
Critical Care Drugs and Non-Critical Care Drugs UltraSafe
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Amphastar Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Amphastar Pharmaceuticals Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Acquisitions/Mergers/Takeovers In June, the company completed the acquisition of BAQSIMI from Eli Lilly and Company.
2022 Regulatory Approval In May, the company announced it received the approval from the US FDA, for its Abbreviated New Drug Application (ANDA) Regadenoson injection which is a single dose pre-filled Syringe.
2022 Regulatory Approval In April, the company announced it received the approval for its Abbreviated New Drug Application (ANDA) Ganirelix Acetate Injection from the US FDA.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Amphastar Pharmaceuticals Inc Pfizer Inc Sanofi Eli Lilly and Co Teva Pharmaceutical Industries Ltd
Headquarters United States of America United States of America France United States of America Israel
City Rancho Cucamonga New York Paris Indianapolis Tel Aviv
State/Province California New York Ile-de-France Indiana Tel Aviv
No. of Employees 1,761 88,000 87,994 43,000 35,001
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Mary Ziping Luo, Ph.D. Chief Scientist; Chairman; Chief Operating Officer Executive Board 2005 73
Jack Yongfeng Zhang, Ph.D. Chief Executive Officer; President; Chief Scientific Officer; Director Executive Board 2020 76
William J. Peters President - International Medication Systems, Limited; Executive Vice President - Finance; Treasurer; Director; Chief Financial Officer Executive Board 2022 55
Jacob Liawatidewi Director; Executive Vice President - Sales and Marketing, and Corporate Administration Center Executive Board 2014 49
Rong Zhou Executive Vice President - Scientific Affairs; President - Armstrong; Senior Executive Vice President - Production Center Senior Management 2023 64
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Amphastar Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Amphastar Pharmaceuticals Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward